Skip to main content

Exercise-Induced Colon Ischemia in a Middle-Aged Female Athlete: Response to a Novel Therapeutic Approach of Sildenafil and Fludrocortisone.

Publication ,  Journal Article
Gadi, SRV; Brandt, LJ; Roper, J
Published in: ACG Case Rep J
October 2025

Colon ischemia is the most frequent form of intestinal ischemia. It is likely most commonly caused by mesenteric vasoconstriction in the microvasculature, though such vasoconstriction has never been documented, considering colonic blood flow has already normalized by the time of presentation. Long-distance running is a rare cause, presumably from blood shunting away from splanchnic vasculature. No effective treatment has previously been reported. We present a 41-year-old woman with recurrent abdominal pain and hematochezia after exercise. Initial workup was unrevealing, prompting a clinical diagnosis of exercise-induced colon ischemia from transient, reversible mesenteric vasoconstriction. Treatment with the vasodilator sildenafil and fludrocortisone for blood pressure support resulted in symptom resolution and her ability to return to exercise without adverse gastrointestinal symptoms.

Duke Scholars

Published In

ACG Case Rep J

DOI

ISSN

2326-3253

Publication Date

October 2025

Volume

12

Issue

10

Start / End Page

e01864

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gadi, S. R. V., Brandt, L. J., & Roper, J. (2025). Exercise-Induced Colon Ischemia in a Middle-Aged Female Athlete: Response to a Novel Therapeutic Approach of Sildenafil and Fludrocortisone. ACG Case Rep J, 12(10), e01864. https://doi.org/10.14309/crj.0000000000001864
Gadi, Sanjay R. V., Lawrence J. Brandt, and Jatin Roper. “Exercise-Induced Colon Ischemia in a Middle-Aged Female Athlete: Response to a Novel Therapeutic Approach of Sildenafil and Fludrocortisone.ACG Case Rep J 12, no. 10 (October 2025): e01864. https://doi.org/10.14309/crj.0000000000001864.
Gadi, Sanjay R. V., et al. “Exercise-Induced Colon Ischemia in a Middle-Aged Female Athlete: Response to a Novel Therapeutic Approach of Sildenafil and Fludrocortisone.ACG Case Rep J, vol. 12, no. 10, Oct. 2025, p. e01864. Pubmed, doi:10.14309/crj.0000000000001864.

Published In

ACG Case Rep J

DOI

ISSN

2326-3253

Publication Date

October 2025

Volume

12

Issue

10

Start / End Page

e01864

Location

United States